Unilateral joint inflammation induces bilateral and time-dependent changes in neuropeptide FF binding in the superficial dorsal horn of the rat spinal cord: Implication of supraspinal descending systems

Brain Research

Volumn 816, Issue 2, 1999, Pages 598-608

  Lombard, Marie Christine ^b,c   Weil Fugazza, Jeanne ^b   Ries, Colette ^a   Allard, Michèle ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM   (France)

^c PSL RESEARCH UNIVERSITY   (France)

Author keywords

Chronic pain; Descending inhibitory control; Monoarthritis; Neuropeptide FF; Nociception; Rat spinal cord

Indexed keywords

NEUROPEPTIDE FF;

ANIMAL EXPERIMENT; ARTHRITIS; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; SENSORY NERVE; SPINAL CORD DORSAL HORN;

ANIMALS; ARTHRITIS, EXPERIMENTAL; FUNCTIONAL LATERALITY; MALE; NEURAL INHIBITION; NEUROPEPTIDES; OLIGOPEPTIDES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; TIME FACTORS;

EID: 0033596568     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01242-6     Document Type: Article

References (59)

1. Allard M., Geoffre S., Legendre P., Vincent J.D., Simonnet G. Characterization of rat spinal cord receptors to FLFQPQRFamide, a mammalian morphine modulating peptide: binding study. Brain Res. 500:1989;169-176.
2. Allard M., Theodosis D.T., Rousselot P., Lombard M.C., Simonnet G. Characterization and localization of a putative morphine-modulating peptide, FLFQPQRFamide, in the rat spinal cord: biochemical and immunocytochemical studies. Neuroscience. 40:1991;81-92.
3. Allard M., Zajac J.M., Simonnet G. Autoradiographic distribution of receptors to FLFQPQRFamide, morphine-modulating peptide, in the rat central nervous system. Neuroscience. 49:1992;101-116.
4. Allard M., Jordan D., Zajac J.M., Ries C., Martin D., Monkouanga D., Kopp N., Simonnet G. Autoradiographic localization of receptors for neuropeptide FF, FLFQPQRFamide, in human spinal sensory system. Brain Res. 633:1994;127-132.
5. M. Allard, M.C. Lombard, C. Ries, J. Weil-Fugazza, Changes in NPFF binding intensity in spinal cord of monoarthritic rats: involvement of supraspinal controls, Abstract 8th World Congress on Pain, 1996, Vancouver, BC, Canada August 17-22.
6. Besse D., Weil-Fugazza J., Lombard M.C., Butler S., Besson J.M. Monoarthritis induces complex changes in mu-, delta- and kappa-opioid binding sites in the superficial dorsal horn of the rat spinal cord. Eur. J. Pharmacol. 223(2-3):1992;123-131.
7. Besson J.M., Chaouch A. Peripheral and spinal mechanism of nociception. Physiol. Rev. 67:1987;67-186.
8. Brandt S.A., Livingston A. Receptor changes in the spinal cord of sheep associated with exposure to chronic pain. Pain. 42:1990;323-330.
9. Butler S.H., Godefroy F., Besson J.M., Weil-Fugazza J. A limited model for chronic pain studies in the rat. Pain. 48:1992;73-81.
10. Butler S.H., Weil-Fugazza J. The foot-bend procedure as test of nociception for chronic studies in a model of monoarthritis in the rat. Pharmacol. Commun. 4:1994;327-334.
11. Castro-Lopes J.M., Tavares I., Tölle T.R., Coito A., Coimbra A. Increase in GABAergic cells and GABA levels in the spinal cord in unilateral inflammation of the hindlimb in the rat. Eur. J. Neurosci. 4:1992;296-301.
12. Castro-Lopes J.M., Tölle T.R., Pan B., Zieglgänsberger W. Expression of GAD mRNA in spinal cord neurons of normal and monoarthritic rats. Mol. Brain Res. 26:1994;169-176.
13. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
14. Culberson J.L., Haines D.E., Kimmel D.L., Brown B.P. Contralateral projection of primary afferent fibers to mammalian spinal cord. Exp. Neurol. 64:1979;83-97.
15. Devilliers J.P., Mazarguil H., Allard M., Dickenson A.H., Zajac J.M., Simonnet G. Characterization of a potent agonist for NPFF receptors: binding study on rat spinal cord membranes. Neuropharmacology. 33(5):1994;661-669.
16. Devilliers J.P., Simonnet G. Modulation of neuropeptide FF release from rat spinal cord slices by glutamate. Involvement of NMDA receptors. Eur. J. Pharmacol. 271(1):1994;185-192.
17. Dubner R., Ruda M.A. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci. 15(3):1992;96-103.
18. M. Fitzgerald, The course and termination of primary afferent fibres, in: P.D. Wall, R. Melzach, (Eds.), Textbook of Pain, Churchill Livingstonre, Edinburg, 1989, pp. 46-62.
19. Gicquel S., Mazarguil H., Allard M., Simonnet G., Zajac J.M. Analogues of F8Famide resistant to degradation, with high affinity and in vivo effects. Eur. J. Pharmacol. 222:1992;61-67.
20. Gouardères C., Sutak M., Zajac J.M., Jhamandas K. Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat. Eur. J. Pharmacol. 237:1993;73-81.
21. Gouardères C., Jhamandas K., Sutak M., Zajac J.M. Analogs of neuropeptide FF modulate spinal nociception in the rat. Regulatory Peptides S. 1:1994;S113-S114.
22. Gouardères C., Jhamandas K., Sutak M., Zajac J.M. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogs. Br. J. Pharmacol. 117:1996;493-501.
23. Gouardères C., Kar S., Zajac J.M. Presence of neuropeptide FF receptors on primary afferent fibres of the rat spinal cord. Neuroscience. 74:1996;21-27.
24. Guzman A., Legendre P., Allard M., Geoffre S., Vincent J.D., Simonnet G. Electrophysiological effects of FLFQPQRFamide, an endogenous brain morphine modulating peptide, on cultured mouse spinal cord neurons. Neuropeptides. 14:1989;253-261.
25. Hökfelt T., Zhang X., Wiesenfeld-Hallin Z. Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci. 17(1):1994;22-30.
26. Hunter W., Greenwood E.G. Preparation of iodine 131 labeled human growth hormone of high specific activity. Nature. 194:1962;495-496.
27. Kivipelto L., Majane E.A., Yang H.-Y.T., Panula P. Immunohistochemical distribution and partial characterization of FLFQPQRFamide-like (morphine-modulating) peptides in the rat brain. Neuroscience. 41:1989;137-148.
28. Kivipelto L., Panula P. Central neural pathways containing FLFQPQRF amide like peptides in the central nervous system of rats. J. Comp. Neurol. 286:1991;269-287.
29. Kivipelto L., Panula P. Origin and distribution of neuropeptide-FF-like immunoreactivity in the spinal cord of rats. J. Comp. Neurol. 307:1991;107-119.
30. 2-adrenergic and μ-opioid spinal antinociception by neuropeptide FF. Peptides. 16:1995;973-977.
31. Kontinen V.K., Aarnisalo A.A., Idäpään-Heikkilä J.J., Panula P., Kalso E.A. Neuropeptide FF in the rat spinal cord during carrageenan inflammation. Peptides. 18(2):1997;287-292.
32. Lanteri-Minet M., de Pommery J., Herdegen T., Weil-Fugazza J., Bravo R., Menétrey D. Differential time course and spatial expression of Fos, Jun and Krox-24 proteins in spinal cord of rats undergoing subacute or chronic somatic inflammation. J. Comp. Neurol. 333:1993;223-235.
33. Lanteri-Minet M., Weil-Fugazza J., de Pommery J., Menetrey D. Hindbrain structures involved in pain processing as revealed by the expression of c-Fos and other immediate early gene proteins. Neuroscience. 58(2):1994;287-298.
34. Leah J.D., Porter D., de Pommery J., Menetrey D., Weil-Fugazza J. Effect of acute stimulation on Fos expression in spinal neurons in the presence of persisting C-fiber activity. Brain Res. 719:1996;104-111.
35. Light A.R., Perl E.R. Reexamination of the dorsal root projection to the spinal dorsal horn including observations on the differential termination of coarse and fine fibers. J. Comp. Neurol. 186:1979;117-132.
36. Lombard M.C., Simonnet G., Zajac J.M., Besson J.M., Allard M. Distribution of neuropeptide FF (FLFQPQRFamide) receptors in the adult rat spinal cord: effects of dorsal rhizotomy and neonatal capsaicin. Neuroscience. 68:1995;1229-1235.
37. 2 with μ and δ opioid antinociception in the rat spinal cord. Neuropeptides. 16:1990;213-218.
38. Majane E.A., Yang H.-Y.T. Distribution and characterization of two putative endogenous opioid antagonist peptides in bovine brain. Peptides. 8:1987;657-662.
39. Majane E.A., Casanova M.F., Yang H.-Y.T. Biochemical characterization of FMRFamide-like peptides in spinal cords of various mammalian species using specific radioimmunoassay. Peptides. 9:1988;1137-1144.
40. Majane E.A., Panula P., Yang H.-Y.T. Rat brain regional distribution and spinal cord neuronal pathway of FLFQPQRF-NH2, a mammalian FMRF-NH2-like peptide. Brain Res. 494:1989;1-12.
41. 2 like mammalian octapeptide: possible role in opiate dependence and abstinence. Peptides. 11:1990;969-972.
42. Malin D.H., Lake J.R., Arcangeli K'A.R., Deshotel K.D., Hausan D., Witherspoon W.E., Carter V.A., Yang H.-Y.T., Pal B., Burgess K. Subcutaneous injection of an analog of neuropeptide FF precipitates morphine abstinence syndrome. Life Sci. 53:1993;261-266.
43. Mapp P.I., Terenghi G., Walsh D.A., Chen S.T., Cruwys S.C., Garrett N., Kidd B.L., Polak J.M., Blake D.R. Monoarthritis in the rat knee induces bilateral and time-dependent changes in substance P and calcitonin gene-related peptide immunoreactivity in the spinal cord. Neuroscience. 57:1993;1091-1096.
44. Merrifield R.B. Solid phase peptide synthesis. J. Am. Chem. Soc. 85:1963;123-128.
45. Miller J.J., Schultz G.S., Levy R.S. Rapid purification of radioiodinated peptide with Sep-Pak reverse phase cartridges and HPLC. Int. J. Pep. Prot. Res. 24:1984;112-122.
46. Molander C., Grant G. Cutaneous projections from the rat hindlimb foot to the substantia gelatinosa of the spinal cord studied by transganglionic transport of WGA-HRP conjugate. J. Comp. Neurol. 237:1985;476-484.
47. Oberling P., Stinus L., Le Moal M., Simonnet G. Biphasic effect on nociception and antiopiate activity of the neuropeptide FF (FLFQPQRFamide) in the rat. Peptides. 14:1993;919-924.
48. Oku R., Satoh M., Tagaki H. Release of substance P from the spinal cord is enhanced in polyarthritic rats. Neurosci. Lett. 74:1987;315-319.
49. Ren K., Dubner R. Enhanced descending modulation of nociception in rats with persistent hindpaw inflammation. J. Neurophysiol. 76:1996;3025-3037.
50. Schaible H.G., Jarrott B., Hope P.J., Duggan A.W. Release of immunoreactive substance P in the spinal cord during development of acute arthritis in the knee joint of the cat: a study with antibody microprobes. Brain Res. 529(1-2):1990;214-223.
51. Schaible H.G., Neugebauer V., Cervero F., Schmidt R.F. Changes in tonic descending inhibition of spinal neurons with articular input during the development of acute arthritis in the cat. J. Neurophysiol. 66(3):1991;1021-1032.
52. Schaible H.G., Grubb B.D. Afferent and spinal mechanism of joint pain. Pain. 55:1993;5-54.
53. Sluka K.A., Westlund K.N. An experimental arthritis in rats: dorsal horn aspartate and glutamate increases. Neurosci. Lett. 145:1992;141-144.
54. Sluka K., Westlund K.N. Behavioral and immunohistochemical changes in an experimental arthritis model in rats. Pain. 55(3):1993;367-377.
55. Stinus L., Allard M., Gold L., Simonnet G. Changes in CNS neuropeptide FF-like material, pain sensitivity, and opiate dependence following chronic morphine treatment. Peptides. 16(7):1995;1235-1241.
56. Sullivan A.F., Kalso E.A., McQuay H.J., Dickenson A.H. FLFQPQRF-amide modulates a2-adrenergic antinociception in the rat dorsal horn in vivo. Brain Res. 562:1991;327-328.
57. Yang H.-Y.T., Fratta W., Majane E.A., Costa E. Isolation, sequencing, synthesis and pharmacological characterization of two neuropeptides that modulate the action of morphine. Proc. Natl. Acad. Sci. U.S.A. 82:1985;7757-7761.
58. 2) from rat spinal cord. Brain Res. 592:1992;326-332.
59. Zimmerman M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.